Skip to main content
. 2021 Jan 25;40:41. doi: 10.1186/s13046-021-01844-7

Fig. 2.

Fig. 2

CBR3-AS1 affects breast cancer cell drug resistance. a, b P-gp expression was measured by western blot after CBR3-AS1 was overexpressed or silenced. The drug treatments comprised 100 nM ADR to MCF-7 cells and 30 μM ADR to MCF-7/ADR cells before culture for 48 h. c, d The fluorescence intensity of ADR was detected by flow cytometry, showing intracellular ADR accumulation. e, f Drug resistance was examined by CCK-8 assays in cells transfected with CBR3-AS1 overexpression plasmid or siRNAs. g, h Cells transfected with the CBR3-AS1 overexpression plasmid or siRNAs were seeded onto plates. The number of colonies was counted on the 14th day after seeding. i Apoptosis rates of MCF-7 cells treated with 100 nM ADR were detected. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001